Enanta Pharmaceuticals (ENTA) Other Non Operating Income (2012 - 2022)

Enanta Pharmaceuticals' Other Non Operating Income history runs 11 years deep, the most recent figure standing at -$942000.0 for Q3 2022.

• Quarterly Other Non Operating Income rose 43.29% year-over-year to -$942000.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was -$36000.0 (changed N/A YoY) and the FY2020 annual result came in at $1.7 million, up 373.85% from the prior year.
• Other Non Operating Income was -$942000.0 for Q3 2022 at Enanta Pharmaceuticals, down from $393000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $2.4 million in Q2 2019 and bottomed at -$7.2 million in Q3 2019.
• A 5-year average of -$205647.1 and a median of $258000.0 in 2021 frame the typical range for Other Non Operating Income.
• Peak annual rise in Other Non Operating Income reached 24050.0% in 2019, while the deepest fall reached 1753.11% in 2019.
• Enanta Pharmaceuticals' Other Non Operating Income stood at -$386000.0 in 2018, then jumped by 637.82% to $2.1 million in 2019, then sank by 67.39% to $677000.0 in 2020, then plunged by 61.89% to $258000.0 in 2021, then plunged by 465.12% to -$942000.0 in 2022.
• Business Quant data shows ENTA's Other Non Operating Income at -$942000.0 in Q3 2022, $393000.0 in Q2 2022, and $255000.0 in Q1 2022.